The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation
Open accessAbstract
To examine the relationship between smoking and Alzheimer's disease (AD) after controlling for study design, quality, secular trend, and tobacco industry affiliation of the authors, electronic databases were searched; 43 individual studies met the inclusion criteria. For evidence of tobacco industry affiliation, http://legacy.library.ucsf.edu was searched. One fourth (11/43) of individual studies had tobacco-affiliated authors. Using random effects meta-analysis, 18 case control studies without tobacco industry affiliation yielded a non-significant pooled odds ratio of 0.91 (95% CI, 0.75-1.10), while 8 case control studies with tobacco industry affiliation yielded a significant pooled odds ratio of 0.86 (95% CI, 0.75-0.98) suggesting that smoking protects against AD. In contrast, 14 cohort studies without tobacco-industry affiliation yielded a significantly increased relative risk of AD of 1.45 (95% CI, 1.16-1.80) associated with smoking and the three cohort studies with tobacco industry affiliation yielded a non-significant pooled relative risk of 0.60 (95% CI 0.27-1.32). A multiple regression analysis showed that case-control studies tended to yield lower average risk estimates than cohort studies (by -0.27 +/- 0.15, P=0.075), lower risk estimates for studies done by authors affiliated with the tobacco industry (by -0.37 +/- 0.13, P=0.008), no effect of the quality of the journal in which the study was published (measured by impact factor, P=0.828), and increasing secular trend in risk estimates (0.031/year +/- 0.013, P=0.02). The average risk of AD for cohort studies without tobacco industry affiliation of average quality published in 2007 was estimated to be 1.72 +/- 0.19 (P< 0.0005). The available data indicate that smoking is a significant risk factor for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“This has been true for sponsorship not only from the tobacco industry [30,31] but also from the pharmaceutical [32,33] and chemical industries [34].”
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816 · cited 1×
“Industry sponsored research is more likely to reach conclusions that are favorable to the sponsor and experience publication bias, publication delays, and data withholding [29].”
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Traditional reviews, meta-analyses and pooled analyses in epidemiology
Blettner, M. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.1.1 · Cited by 594
Ockene, I. S., & Miller, N. H. (1997) · Circulation · doi:10.1161/01.cir.96.9.3243 · Cited by 541
Ott, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535
Alzheimer's disease: A study of epidemiological aspects
Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984) · Annals of Neurology · doi:10.1002/ana.410150406 · Cited by 525
Does blinding of readers affect the results of meta-analyses?
Berlin, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62352-5 · Cited by 478 · cited 1×
“In a study of blinding in 5 metaanalyses, blinding made no difference in the pooled risk estimates.[60] In the document search for tobacco industry affiliation, we may not have retrieved every relevant document.”
Development of dementing illnesses in an 80‐year‐old volunteer cohort
Katzman, R., Aronson, M., Fuld, P., Kawas, C., Brown, T., Morgenstern, H., Frishman, W., Gidez, L., Eder, H., & Ooi, W. L. (1989) · Annals of Neurology · doi:10.1002/ana.410250402 · Cited by 452
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Why review articles on the health effects of passive smoking reach different conclusions
Barnes, D. E. (1998) · JAMA · doi:10.1001/jama.279.19.1566 · Cited by 442
Friedland, R. P., Fritsch, T., Smyth, K. A., Koss, E., Lerner, A. J., Chen, C. H., Petot, G. J., & Debanne, S. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061002998 · Cited by 437
Bazzano, L. A., He, J., Muntner, P., Vupputuri, S., & Whelton, P. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00010 · Cited by 407
Free testosterone and risk for Alzheimer disease in older men
Moffat, S. D., Zonderman, A. B., Metter, E. J., Kawas, C., Blackman, M. R., Harman, S. M., & Resnick, S. M. (2004) · Neurology · doi:10.1212/wnl.62.2.188 · Cited by 383
Scollo, M., Lal, A., Hyland, A., & Glantz, S. (2003) · Tobacco Control · doi:10.1136/tc.12.1.13 · Cited by 369
Self-citationAmaducci, L. A., Fratiglioni, L., Rocca, W. A., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.922 · Cited by 365
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357
Chapman, S. (1996) · BMJ · doi:10.1136/bmj.312.7045.1550 · Cited by 339
The Quality of Drug Studies Published in Symposium Proceedings
Cho, M. K., & Bero, L. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-5-199603010-00004 · Cited by 328
Implications of the Tobacco Industry Documents for Public Health and Policy
Bero, L. (2003) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.24.100901.140813 · Cited by 302
Graves, A. B., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s48 · Cited by 246
Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies
Fratiglioni, L., & Wang, H.-X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00206-0 · Cited by 245
A CASE-CONTROL STUDY OF DEMENTIA OF THE ALZHEIMER TYPE
FRENCH, L. R., SCHUMAN, L. M., MORTIMER, J. A., HUTTON, J. T., BOATMAN, R. A., & CHRISTIANS, B. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114013 · Cited by 244
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
Tobacco industry documents: treasure trove or quagmire?
Malone, R. E. (2000) · Tobacco Control · doi:10.1136/tc.9.3.334 · Cited by 235
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231
Bero, L. A. (2005) · Public Health Reports® · doi:10.1177/003335490512000215 · Cited by 229
Smoking and Alzheimer's Disease: A Review of the Epidemiological Evidence
Lee, P. N. (1994) · Neuroepidemiology · doi:10.1159/000110372 · Cited by 206
The influence of smoking on the risk of Alzheimer’s disease
Merchant, C., Tang, M.-X., Albert, S., Manly, J., Stern, Y., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.52.7.1408 · Cited by 197
Relation between nicotine intake and Alzheimer's disease.
van Duijn, C. M., & Hofman, A. (1991) · BMJ · doi:10.1136/bmj.302.6791.1491 · Cited by 197
Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study
Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., & Breteler, M. M. B. (2007) · Neurology · doi:10.1212/01.wnl.0000271395.29695.9a · Cited by 195
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
Risk factors for Alzheimer's disease: A case‐control study
Shalat, S. L., Seltzer, B., Pidcock, C., & Baker, E. L. (1987) · Neurology · doi:10.1212/wnl.37.10.1630 · Cited by 184
Brenner, D. E., Kukull, W. A., van Belle, G., Bowen, J. D., McCormick, W. C., Teri, L., & Larson, E. B. (1993) · Neurology · doi:10.1212/wnl.43.2.293 · Cited by 183
Almeida, O. P., Hulse, G. K., Lawrence, D., & Flicker, L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00016.x · Cited by 175
Broe, G. A., Creasey, H., Jorm, A. F., Bennett, H. P., Casey, B., Waite, L. M., Grayson, D. A., & Cullen, J. (1998) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1998.tb01449.x · Cited by 169
MRCPsych, M. P., FRANZCP, M. C., & Mann, A. (1994) · Neurology · doi:10.1212/wnl.44.1.97 · Cited by 163
Cigarette Smoking and Dementia: Potential Selection Bias in the Elderly
Hernán, M. A., Alonso, A., & Logroscino, G. (2008) · Epidemiology · doi:10.1097/ede.0b013e31816bbe14 · Cited by 159
An Epidemiological Study of Dementia in a Rural Community in Kerala, India
Shaji, S., Promodu, K., Abraham, T., Roy, K. J., & Verghese, A. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.6.745 · Cited by 156
Forster, D. P., Newens, A. J., Kay, D. W. K., & Edwardson, J. A. (1995) · Journal of Epidemiology & Community Health · doi:10.1136/jech.49.3.253 · Cited by 146
Are Alzheimer Patients Healthier?
Wolf‐Klein, G. P., Silverstone, F. A., Brod, M. S., Levy, A. P., Foley, C. J., Termotto, V., & Breuer, J. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb01804.x · Cited by 140
Aggarwal, N. T., Bienias, J. L., Bennett, D. A., Wilson, R. S., Morris, M. C., Schneider, J. A., Shah, R. C., & Evans, D. A. (2006) · Neuroepidemiology · doi:10.1159/000091654 · Cited by 137
Case‐control study of late onset “probable Alzheimer's disease”
Chandra, V., Philipose, V., BELL, P. A., Lazaroff, A. E., & Schoenberg, B. S. (1987) · Neurology · doi:10.1212/wnl.37.8.1295 · Cited by 131
Smoking and dementia in male British doctors: prospective study
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2000) · BMJ · doi:10.1136/bmj.320.7242.1097 · Cited by 129
van Duijn, C. M., Clayton, D. G., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110609 · Cited by 129
Relation of Smoking and Alcohol Consumption to Incident Alzheimer's Disease
Hebert, L. E., Scherr, P. A., Beckett, L. A., Funkenstein, H. H., Albert, M., Chown, M. J., & Evans, D. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116296 · Cited by 129
Brain neurotransmitters and receptors in aging and age-related disorders
Enna, S. J., Samorajski, T., & Beer, B. (1981) · Medical Entomology and Zoology · Cited by 118
A 2‐year follow‐up study of cigarette smoking and risk of dementia
Juan, D., Zhou, D. H. D., Li, J., Wang, J. Y. J., Gao, C., & Chen, M. (2004) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00779.x · Cited by 118
Cardiovascular and Other Risk Factors for Alzheimer's Disease and Vascular Dementia
Meyer, J. S., Rauch, G. M., Rauch, R. A., Haque, A., & CRAWFORD, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06393.x · Cited by 113
Piguet, O., Grayson, D. A., Creasey, H. M., Bennett, H. P., Brooks, W. S., Waite, L. M., & Broe, G. A. (2003) · Neuroepidemiology · doi:10.1159/000069886 · Cited by 111
Wang, H.-X., Fratiglioni, L., Frisoni, G. B., Viitanen, M., & Winblad, B. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009864 · Cited by 110
Prevalence of Alzheimer's type dementia in an elderly Arab population
Bowirrat, A., Treves, T. A., Friedland, R. P., & Korczyn, A. D. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00183.x · Cited by 85
Alcohol use and the risk of developing Alzheimer's disease.
Tyas, S. L. (2001) · PubMed Central · Cited by 85
A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics
Harwood, D. G., Barker, W. W., Loewenstein, D., Ownby, R. L., George‐Hyslop, P. S., MULLAN, M. J., & Duara, R. (1999) · Neurology · doi:10.1212/wnl.52.3.551 · Cited by 83
Ferini‐Strambi, L., Smirne, S., Garancini, P., Pinto, P., & Franceschi, M. (1990) · Neuroepidemiology · doi:10.1159/000110750 · Cited by 71
The limits of competing interest disclosures.
Bero, L. A., Glantz, S. A., & Hong, M.-K. (2005) · PubMed · Cited by 67
Self-citationThe association between smoking and Alzheimer’s disease: effects of study design and bias
Kukull, W. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01077-5 · Cited by 59
Comparison of Alzheimer’s disease risk factors in white and African American families
Bachman, D., Green, R. C., Benke, K. S., Cupples, L. A., & Farrer, L. A. (2003) · Neurology · doi:10.1212/01.wnl.0000058751.43033.4d · Cited by 59
A CASE-CONTROL STUDY OF SMOKING AND ALZHEIMER'S DISEASE
Salib, E., & Hillier, V. F. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199703)12:3<295::aid-gps476>3.0.co;2-3 · Cited by 46
Tyas, S. L., Koval, J. J., & Pederson, L. L. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1685::aid-sim454>3.0.co;2-# · Cited by 41
Risk Factors for Alzheimer’s Disease: A Case-Control Study
Wang, P., Wang, S., Hong, C., Liu, T.-T., Fuh, J., Chi, C., LIU, C., & Liu, H.-C. (1997) · Neuroepidemiology · doi:10.1159/000109692 · Cited by 40
Playing hide‐and‐seek with the tobacco industry
LeGresley, E., Muggli, M. E., & Hurt, R. D. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200412331328529 · Cited by 38
Clinical Implications of Smoking and Aging: Breaking Through the Barriers
Cataldo, J. K. (2007) · Journal of Gerontological Nursing · doi:10.3928/00989134-20070801-06 · Cited by 36
Self-citationTurner, C., & Spilich, G. J. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02863.x · Cited by 29
Influence of design characteristics on the outcome of retrospective cohort studies.
Swaen, G. M. H., & Meijers, J. M. M. (1988) · Occupational and Environmental Medicine · doi:10.1136/oem.45.9.624 · Cited by 25
Smoking as a Risk Factor for Alzheimer's Disease
Grossberg, G. T., Nakra, R., Woodward, V., & Russell, T. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb02247.x · Cited by 24
Alzheimer's disease and smoking: bias in cohort studies
Debanne, S. M., Bielefeld, R. A., Cheruvu, V. K., Fritsch, T., & Rowland, D. Y. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11308 · Cited by 20
Smoking, Alzheimer's disease, and confounding with genes
Plassman, B. L., Helms, M. J., Welsh, K. A., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90374-7 · Cited by 19
Hirayama, T. T. (1992) · Tobacco Control · doi:10.1136/tc.1.3.176 · Cited by 16
Association of Alzheimer's Disease and Smoking: The Case for Sibling Controls
Debanne, S. M., Rowland, D. Y., Riedel, T. M., & Cleves, M. A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04756.x · Cited by 14
Chen, G., Payne, T. J., Lou, X.-Y., Ma, J. Z., Zhu, J. Z., & Li, M. D. (2008) · Human Genetics · doi:10.1007/s00439-008-0558-9 · Cited by 11
Salib, E. (2000) · Aging & Mental Health · doi:10.1080/713649926 · Cited by 8
Cited by
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173
Metadata
- Authors
- Cataldo, J. K., Prochaska, J. J., & Glantz, S. A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-07
- Volume
- 19
- Issue
- 2
- Pages
- 465-480
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1603997350
- Cited by
- 335
- References
- 79
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.